Hannah F Almubarak (Hannah Almubarak)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Angiotensin Converting Enzyme

Top Venues

Science (New York, N.Y.)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Nurmaa K Dashzeveg, Yuzhi Jia, Youbin Zhang, Lorenzo Gerratana, Priyam A Patel, Asif Shajahan, Tsogbadrakh Dandar, Erika K Ramos, Hannah F Almubarak, Valery Adorno-Cruz, Rokana Taftaf, Emma J Schuster, David Scholten, Michael T Sokolowski, Giancarlo Feliciello, Lamiaa El-Shennawy, Andrew D Hoffmann, Maroua Manai, Qiang Zhang, Paolo D'Amico, Parastoo Azadi, Karen J Colley, Leonidas C Platanias, Ami N Shah, William J Gradishar, Massimo Cristofanilli, William A Muller, Brian A Cobb, Huiping Liu
Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer. Cancer discovery (2023)
Neil T Umbreit, Cheng-Zhong Zhang, Luke D Lynch, Logan J Blaine, Anna M Cheng, Richard Tourdot, Lili Sun, Hannah F Almubarak, Kim Judge, Thomas J Mitchell, Alexander Spektor, David Pellman
Mechanisms generating cancer genome complexity from a single cell division error. Science (New York, N.Y.) 368 (6488) (2020)
Lamyaa Alghofaili, Hannah F Almubarak, Khawlah Gassem, Syed S Islam, Serdar Coskun, Namik Kaya, Bedri Karakas
Cell-free DNA levels of twins and sibling pairs indicate individuality and possible use as a personalized biomarker. PloS one 14 (10) (2019)